Hee-Cheol Kim | Physiology | Best Researcher Award-duplicate-1

Posted on by sciencefather

Prof. Dr. Hee-Cheol Kim | Neuroscience | Best Researcher Award

Professor at Keimyung University School of Medicine, South Korea.

Dr. Hee-Cheol Kim is a seasoned psychiatrist and researcher with over three decades of academic, clinical, and administrative experience. His extensive body of work focuses on neurodegenerative diseases, mental health, type 2 diabetes, and the application of electroconvulsive therapy (ECT). His contributions include numerous publications in reputable journals, a history of leadership roles, and impactful research collaborations.

Profile

Orcid

 

Education 🎓:

Dr. Hee-Cheol Kim began his medical education at Keimyung University School of Medicine, earning his M.D. in 1988. He pursued advanced research in psychiatry, completing his Ph.D. in 2001 at Kyungpook National University. His postgraduate training included a rotating internship and residency in psychiatry at Keimyung University Dongsan Medical Center, solidifying his expertise in mental health care. Dr. Kim’s commitment to global learning led him to New York University School of Medicine, where he served as a visiting professor at the Aging and Dementia Research Center. His multidisciplinary academic foundation and international exposure underpin his innovative contributions to psychiatry and neuropsychiatric research.

Work Experience 💼:

Dr. Hee-Cheol Kim’s career spans academic, clinical, and administrative roles. Since 1996, he has been affiliated with Keimyung University School of Medicine, rising from lecturer to professor. He held prestigious positions, including Dean of the School of Medicine and Vice President of Keimyung University Dongsan Hospital. His administrative expertise extends to directing medical affairs and mental health centers in South Korea. Dr. Kim also led the Keimyung University Brain Research Institute, driving advancements in neuroscience. Internationally, he served as a visiting professor at NYU, where he contributed to dementia research. His leadership, combined with his dedication to patient care and teaching, has made him a pillar in the psychiatric community.

Awards and Honors 🏆

Dr. Hee-Cheol Kim has received numerous accolades for his contributions to psychiatry and medical education. His groundbreaking research in dementia, mental health, and neurodegenerative diseases has earned him recognition within the academic and medical communities. Dr. Kim has been honored by prestigious organizations, including the Korean Neuropsychiatric Association and the Korean Society for Affective Disorders. His leadership in psychiatry education has also been acknowledged through awards for his excellence in teaching and mentorship. As a member of multiple national and international psychiatric organizations, he has been celebrated for his dedication to advancing mental health care and fostering interdisciplinary collaborations in research and clinical practice.

Research Interests:

Dr. Hee-Cheol Kim’s research is centered on neuropsychiatry, focusing on dementia, neurodegenerative diseases, and the intersection of mental health with chronic medical conditions like type 2 diabetes. He is a pioneer in using electroconvulsive therapy (ECT) for treatment-resistant psychiatric disorders and neurodevelopmental challenges. His studies explore how conditions such as depression and Alzheimer’s influence comorbidities, providing critical insights into geriatric mental health. During his tenure at NYU, he contributed to dementia research, emphasizing early diagnosis and interventions. Dr. Kim’s recent work includes investigating the impact of COVID-19 on mental health and the association between chronic diseases and neurodegeneration. His research bridges clinical practice and academia, offering innovative solutions to improve patient outcomes and enhance mental health care.

📚 Publications 

  • “Risk of dementia in patients with age‐related medical conditions: a retrospective cohort study”
    • Authors: Not specified in accessible sources.
    • Published in: Psychogeriatrics
    • Year: 2024
    • DOI: 10.1111/psyg.13222
  • “Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Yeungnam Medical Science
    • Year: 2024
    • DOI: 10.12701/jyms.2023.01256
  • “Effectiveness and Tolerability of Combination Pharmacotherapy With Stimulant and Non-Stimulant in Children With Attention Deficit Hyperactivity Disorder”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of the Korean Academy of Child and Adolescent Psychiatry
    • Year: 2024
    • DOI: 10.5765/jkacap.230048
  • “Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Diabetes Research
    • Year: 2023
    • DOI: 10.1155/2023/7887792
  • “The Association Between Cancer and Neurodegenerative Diseases: A Retrospective Cohort Study Using the National Health Insurance Service-National Health Information Database”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Korean Neuropsychiatric Association
    • Year: 2021
    • DOI: 10.4306/jknpa.2021.60.4.307

Conclusion 

Dr. Hee-Cheol Kim stands out as a compelling candidate for the Best Researcher Award due to his prolific academic record, innovative contributions to psychiatry, and significant influence on mental health practices in Korea and beyond. His career demonstrates a harmonious blend of research, teaching, and leadership, making him an exemplary figure in the field. Strengthening interdisciplinary collaborations and expanding his international footprint would further cement his legacy as a leading researcher.

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

K S V POORNA CHANDRIKA | Cognitive Development| Best Researcher Award

Posted on by sciencefather

Dr. K S V POORNA CHANDRIKA | Cognitive Development| Best Researcher Award

Dr.K S V POORNA CHANDRIKA,ICAR-Indian Institute of Oilseeds Research, Tiruchirappalli,India

Dr. K S V Poorna Chandrika is a prominent scientist affiliated with the ICAR-Indian Institute of Oilseeds Research in Tiruchirappalli, India. Her research primarily focuses on various aspects of oilseed crops, including breeding, genetics, and sustainable agricultural practices. Dr. Poorna Chandrika has made significant contributions to the field through her extensive research and publications, aiming to enhance crop productivity and resilience in challenging agricultural environments. Her work is highly regarded within the scientific community for its practical implications in improving food security and agricultural sustainability.

Professional Profile:

Area of Expertise:

  • Synthesis and characterization of hydrophilic superabsorbent and superporous hydrogels
  • Development of polymeric films as carriers for crop protection inputs
  • Formulation of microbial bioagents and chemicals for seed health and nutrient management
  • Instrumentation expertise: GLC, HPLC, UV spectroscopy, NMR, Electron microscopy, FT-IR, HPTLC, GC, XRD, AAS, DLS, rheometer, ICP, DSC etc.

Contribution to Scientific Advancement:

  • Developed potential polymeric films for management of biotic and abiotic stresses in various pulses and oilseeds
  • Field evaluation of innovative formulations for sustainable agriculture

Awards and Recognition:

    • Best Paper Award at IIOR-2019 for “Development of chitosan-PEG blended films using Trichoderma: Enhancement of antimicrobial activity and seed quality”
    • Best Oral Presentation Award at International Bio Pesticide Conference-2019

Area of Research:

    • Currently researching polymers as formulation carriers and nanosystems for various delivery mechanisms

Publications: 

  • Hydrogels and Superabsorbent Materials: Chandrika KSVP has contributed significantly to research on novel hydrogels, particularly those based on guar gum and poly(acrylate). These hydrogels are characterized for their superabsorbent properties and their behavior in different environments, including simulated environments and plant growth media.
  • Biopesticides and Agricultural Applications: Chandrika KSVP has also explored nanobiopesticides and biopolymeric formulations for agricultural applications. This includes the development of Bacillus thuringiensis-based nanopesticides and other bioformulations for pest management and crop protection.
  • Biopolymer Blends and Coatings: Research extends to the development of biopolymer blends, such as chitosan-PEG films and chitosan-based seed coatings. These innovations aim to enhance antimicrobial activity, seed quality, and stress tolerance in crops against biotic and abiotic factors.
  • Nanotechnology in Agriculture: Chandrika KSVP has contributed to studies involving metal nanoparticles as plant nutrients and their applications through soil application. This includes research on Fe and Zn metal nanocitrates.
  • Patents and Innovations: There are mentions of patents related to polymer compositions and their preparation, indicating a focus on translating research into practical applications and intellectual property.